05:26 AM EDT, 06/05/2025 (MT Newswires) -- Liminatus Pharma ( LIMN ) said late Wednesday that it is now compliant with the Nasdaq listing rule requiring a timely filing of reports with the US Securities and Exchange Commission.

The company was notified of the noncompliance due to a delay in the filing of its quarterly report on Form 10-Q for the period ended March 31.

Liminatus said late Wednesday that it filed the Form 10-Q Monday.

The company's shares were up nearly 82% in recent premarket activity Thursday.